Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2013 023 108.7 |
| 96 | EP file number | EAKZ | 13 72 1857.4 |
| 86 | WO file number | WAKZ | PCT/US2013/037956 |
| 97 | EP publication number | EPN | 2841437 |
| 87 | WO publication number | WPN | 2013163279 |
| 54 | Designation/title | TI | IMIDAZOTHIADIAZOL- UND IMIDAZOPYRAZINDERIVATE ALS PROTEASEAKTIVIERTE REZEPTOR 4 (PAR4)-INHIBITOREN ZUR BEHANDLUNG VON THROMBOZYTENAGGREGATION |
| 51 | IPC main class | ICM
(ICMV) | C07D 519/00 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/433 (2006.01), C07D 513/04 (2006.01), A61K 31/5025 (2006.01), C07D 487/04 (2006.01), A61K 31/4355 (2006.01), A61P 7/02 (2006.01) |
| 22 | DE application date | DAT | Apr 24, 2013 |
| 96 | EP application date | EAT | Apr 24, 2013 |
| 86 | WO application date | WAT | Apr 24, 2013 |
| 43 | Date of first publication | OT | Oct 31, 2013 |
| Date of publication of grant | PET | Jul 5, 2017 |
| 71/73 | Applicant/owner | INH | Bristol-Myers Squibb Company, Princeton, N.J., US; Université de Montréal, Montreal, Quebec, CA |
| 72 | Inventor | IN | BANVILLE, Jacques, Montréal, Québec H3T 1J4, CA; RÉMILLARD, Roger, Napierville, Québec J0J 1L0, CA; RUEDIGER, Edward H., Montréal, Québec H3T 1J4, CA; DEON, Daniel H., Montréal, Québec H3T 1J4, CA; GAGNON, Marc, Montréal, Québec H3T 1J4, CA; DUBÉ, Laurence, Montréal, Québec H3T 1J4, CA; GUY, Julia, Montréal, Québec H3T 1J4, CA; PRIESTLEY, Eldon Scott, Pennington, New Jersey 08534, US; POSY, Shoshana L., Pennington, New Jersey 08543, US; MAXWELL, Brad D., Pennington, New Jersey 08543, US; WONG, Pancras C., Pennington, New Jersey 08534, US; LAWRENCE, Michael, R., Pennington, NJ 08534, US; MILLER, Michael, M., Princeton, NJ 08543, US |
| 74 | Representative | VTR | Marks & Clerk (Luxembourg) LLP, Luxembourg, LU |
| Address for service | | Marks & Clerk (Luxembourg) LLP, 1017 LUXEMBOURG, LU |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201261638577 P
Apr 26, 2012
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201361787680 P
Mar 15, 2013
|
| Due date | FT
FG | Apr 30, 2025
Annual fee for the 13th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002841437
Searchable text:
EP000002841437
Original document:
EP000002841437B1
Searchable text:
EP000002841437B1
Original document:
WO002013163279
Searchable text:
WO002013163279 |
| 43 | Date of first publication | EVT | Oct 31, 2013 |
| Date of the first transfer into DPMAregister | EREGT | Apr 16, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | May 8, 2024
(Show all update days)(Hide all update days)- May 8, 2024; Mar 13, 2024; Mar 9, 2023; Mar 10, 2022; Apr 8, 2021; Apr 23, 2020; Aug 14, 2019; Apr 17, 2019; Jun 21, 2018; May 30, 2018; Apr 24, 2018; Jul 29, 2017; Jul 28, 2017; Jul 12, 2017; Jul 6, 2017; Feb 16, 2017
- Historical data not available for this/these date(s)
- Apr 16, 2015
- Date of the first transfer into DPMAregister
|
